EXPERIENCE OF ANGER IN PATIENTS WITH IRRITABLE BOWEL SYNDROME IN ROMANIA

Authors

  • Mihaela Fadgyas Stănculete
  • Cristina Pojoga
  • Dan Lucian Dumitrașcu

DOI:

https://doi.org/10.15386/cjmed-290

Keywords:

anger, irritable bowel syndrome, brain-gut axis

Abstract

Background and aims. Anger is strongly associated with the coping style, personality, interpersonal conflicts and quality of life. Increased research is being focused on the negative impact of anger on irritable bowel syndrome (IBS). Certain psychological areas such as anger have not been investigated in Romanian patients. The present study aims to determine the basal differences in experiencing anger between IBS patients and controls.

Method. We examined the State-Trait anger in 60 subjects with IBS and 45 controls. The socio-demographic data and the State-Trait Anger Inventory were administered in individual sessions.

Results evidenced that the IBS group had high mean scores for trait anger. No significant differences between the groups were detected on state anger.

Conclusion. Higher levels of trait anger characterize IBS patients when compared to controls and this may be associated with symptoms. These findings are discussed within the context of other data suggesting that trait anger contributes to development and evolution of IBS, perhaps through modulation of the colonic motor activity.

Author Biographies

Mihaela Fadgyas Stănculete, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca

Department of Neurosciences

Cristina Pojoga, Prof Dr Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca Babes-Bolyai University, Cluj-Napoca,

Department of Clinical Psychology and Psychotherapy

Dan Lucian Dumitrașcu, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca

2nd Department of Internal Medicine

Downloads

Published

2014-06-30

How to Cite

1.
Stănculete MF, Pojoga C, Dumitrașcu DL. EXPERIENCE OF ANGER IN PATIENTS WITH IRRITABLE BOWEL SYNDROME IN ROMANIA. Med Pharm Rep [Internet]. 2014 Jun. 30 [cited 2025 Oct. 5];87(2):98-101. Available from: https://medpharmareports.com/index.php/mpr/article/view/290

Issue

Section

Original Research